Goldacre et al.'s above article 1 was read with great interest. In 2008, The North Western Deanery completed a study looking at doctors' career and retirement choices. This included analysis of the geographical movement of 1993-1996 medical graduates from The University of Manchester. Our group was substantially smaller than Goldacre et al.'s sample, with 22 medical trainees participating in interviews and 234 completing questionnaires. However, we too found that trainees often ultimately train or practise where either they or their partner originates from. An element of this was around the increasing need for childcare support from family. This may also offer part explanation for Goldacre et al.'s finding that among their sample more of the younger than older doctors 'settled in the region of their family home'.
It was interesting that the authors also say, 'Younger generations are more likely to take into account the preferences of their spouses than older generations. ' We found that while almost 45% of trainee participants located in the North West at the time of our study grew up in the region, almost a further 20% had a partner who originated from the North West. So in one-fifth of cases, the spouse's possible preferred location had been followed.
We concluded that as it appears that medical trainees choose to subsequently live and work close to the location of family, then to improve retention of this group in the North West it is necessary to thus concentrate on recruiting students into medical schools locally.
Like the authors, we found there to be a lack of research on this topic. 
Catherine Tregoning and Jacky Hayden

Time to promote medical innovation through legislation
We are delighted to hear the Medical Innovation Bill is passing through the House of Lords 1 in the United Kingdom. This is a brand new approach to tackling human diseases through the medical legislation pathway.
As innovation is such a critical driver in medical research and is hard to avoid in medical practice, 2 a new legislation is therefore necessary to encourage it. This will not only benefit clinicians and scientists, but most importantly, will lead to improved patient experience.
The determination of medical negligence in our present law is influenced by evidence-based medicine, 3 so that services provided by health professionals are based on current clinical guidelines. However, as the personalized medicine era is approaching, guidelines for the general population may not be the best choice for a certain patient. In this situation, a novel 'innovative' treatment may be warranted for such an individual. If the fear of litigation under this circumstance overcomes the requirement of innovation, neither the doctor nor the patient would benefit from it. Indeed, primum non nocere is our first priority, nonetheless, the so-called 'defensive medicine' is a dangerous struck between therapeutic innovation and conservatism. 1 Especially in those countries or areas where the medical legislation is underdeveloped such as in China, doctors usually choose the conservative treatment to avoid any potential litigation.
The Bill gives an extraordinary solution to promote medical innovation, and we hope this could lead to a significant contribution leading to worldwide legislation focusing on medical innovation in the future. 
